Vacc-iNTS consortium is composed by 12 partners and brings together academic and industry research teams from 4 European countries (Belgium, Italy, Switzerland and United Kingdom), 4 disease endemic countries (Burkina Faso, Ghana, Kenya and Malawi) and 1 non-EU country (New Zealand). The consortium is characterized by a renowned international expertness on vaccine development and characterization, and poverty-related diseases of developing countries.
The Vacc-iNTS project is coordinated by the Sclavo Vaccines Association (www.sclavo.org), a non-profit organization devoted to support research and development of human vaccines.
Partners
| Sclavo Vaccines Association (SVA) | Italy |  |
| GSK Vaccines Institute for Global Health (GVGH) | Italy |  |
| University of Oxford (UOXF) | United Kingdom |  |
| Kenya Medical Research Institute (KEMRI) | Kenya |  |
| University of Cambridge (UCAM) | United Kingdom |  |
| University of Siena (UNISI) | Italy |  |
| Institute of Tropical Medicine Antwerp (ITM) | Belgium |  |
| University of Liverpool (UOL) | United Kingdom |  |
| University of Otago (UNI OF OTAGO) | New Zealand |  |
| Université Ouaga I Professeur Joseph Ki-Zerbo (OU) | Burkina Faso |  |
| Kwame Nkrumah University of Science and Technology Kumasi (KNUST) | Ghana |  |
| MMGH Consulting GMBH (MMGH) | Switzerland |  |
Linked Third Parties
| Fondazione Achille Sclavo ONLUS | Italy |  |
| Glaxosmithkline Biologicals SA | Belgium | |
| University of Malawi | United Kingdom |  |